Skip to main content
DA

DrugVision.AI

DrugVision.AI automates high-throughput drug screening using AI-driven image analysis to capture and analyze drug response data in real time. This platform enables researchers to obtain precise insights into drug efficacy, accelerating the discovery of new therapeutics while minimizing manual data processing time.

Founded 20232200+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional drug screening methods often involve manual data processing, which is time-consuming and can introduce variability, hindering the rapid discovery of new therapeutics. Researchers need faster, more accurate ways to analyze drug response data to accelerate the drug development pipeline.

Solution

DrugVision.AI offers an automated high-throughput drug screening platform that leverages AI-driven image analysis to capture and analyze drug response data in real time. The platform integrates advanced in vitro models, automation technology, and live-cell imaging to observe cellular responses to drugs. Its core component, the Orbits platform, provides rapid image and data analysis, enabling researchers to obtain precise insights into drug efficacy and identify key trends. By automating the entire drug screening process, DrugVision.AI minimizes manual data processing time and facilitates better-informed decisions in drug development.

Target Audience

The primary target audience includes researchers and drug developers in the pharmaceutical and biotechnology industries, particularly those focused on oncology, ophthalmology, and regenerative medicine.

Features

  • AI-powered image analysis for real-time capture and analysis of drug response data
  • Orbits platform for fast and reliable image and data analysis, handling large datasets with ease
  • High-throughput screening capabilities for efficient drug discovery
  • In vitro models and automation technology for observing cellular responses to drugs
  • Live-cell imaging to monitor cellular dynamics during drug screening
  • Tumor organoid biobank with patient-derived tumor organoid models
  • Automated liquid handling with OT-2 pipetting robot
  • Automated cell culture maintenance with Cytomat 2C automated incubator
  • Advanced imaging with Spark Cyto imaging plate reader and Celldiscoverer 7 + LSM900 confocal microscope
  • Digital dispensing with D300e Digital Dispenser
  • ClinoStar and ClinoReactor for long-term and large-sized 3D cell culturing
This profile is AI-generated and may contain inaccuracies.